Specific antibody response of 14 patients with common variable immunodeficiency to 3 BNT162b2 messenger RNA coronavirus disease 2019 vaccinations.

Abo-Helo, Nizar; Muhammad, Emad; Ghaben-Amara, Sondus; Cohen, Shai

Abo-Helo, Nizar; Muhammad, Emad; Ghaben-Amara, Sondus; Cohen, Shai.

Abo-Helo N; Unit of Allergy and Clinical Immunology, Lin Medical Center, Haifa, Israel; Unit of Allergy and Clinical Immunology, Zvulun Medical Center, Haifa, Israel.
Muhammad E; Hematology Laboratory, Carmel Medical Center, Haifa, Israel.
Ghaben-Amara S; Hematology Laboratory, Carmel Medical Center, Haifa, Israel.
Cohen S; Unit of Allergy and Clinical Immunology, Lin Medical Center, Haifa, Israel; Department of Internal Medicine B, Carmel Medical Center, Haifa, Israel; Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. Electronic address: shaico@technion.ac.il.

Ann Allergy Asthma Immunol ; 129(1): 108-109, 2022 07.

Article in English | MEDLINE | ID: covidwho-1859304

Subject(s)

COVID-19; Common Variable Immunodeficiency; Antibodies; Antibody Formation; BNT162 Vaccine; COVID-19/prevention & control; Common Variable Immunodeficiency/genetics; Humans; RNA, Messenger; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Common Variable Immunodeficiency / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Ann Allergy Asthma Immunol Journal subject: Allergy and Immunology Year: 2022 Document Type: Article Affiliation country: J.anai.2022.03.035

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google